We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

46 hedge funds and large institutions have $29.8M invested in Vaxart in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $29.5M → $29.8M (+$252K)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

6% less funds holding

Funds holding: 49 → 46 (-3)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
11
Reduced
12
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$3.21M
2
SAM
Senzar Asset Management
New York
+$3.05M
3
Renaissance Technologies
Renaissance Technologies
New York
+$392K
4
Deutsche Bank
Deutsche Bank
Germany
+$267K
5
GF
Gabelli Funds
New York
+$43.3K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$2.78M
2
VAM
Visium Asset Management
New York
-$1.48M
3
BA
BlackRock Advisors
Delaware
-$1.09M
4
PA
Perceptive Advisors
New York
-$626K
5
BG
BlackRock Group
United Kingdom
-$391K
Name Holding Trade Value Shares
Change 		Change in
Stake
GF
26
Gabelli Funds
New York
$115K +$43.3K +1,689 +57%
BIM
27
Bogle Investment Management
Massachusetts
$100K -$19.9K -775 -16%
SIM
28
Spark Investment Management
New York
$81K -$37.7K -1,473 -31%
Charles Schwab
29
Charles Schwab
California
$59K – – –
State Street
30
State Street
Massachusetts
$58K -$6.05K -236 -9%
VKH
31
Virtu KCG Holdings
New York
$34K +$35.2K +1,374 New
ARTA
32
A.R.T. Advisors
New York
$31K -$4.2K -164 -11%
PP
33
PDT Partners
New York
$31K – – –
PP
34
Paloma Partners
Connecticut
$31K +$32.2K +1,257 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$28K +$77 +3 +0.3%
BA
36
BlackRock Advisors
Delaware
$22K -$1.09M -42,464 -98%
BIM
37
BlackRock Investment Management
Delaware
$13K – – –
NFA
38
Nationwide Fund Advisors
Ohio
$5K – – –
UBS Group
39
UBS Group
Switzerland
$5K +$5.58K +218 New
RAM
40
Riggs Asset Management
Pennsylvania
$1K – – –
AIG
41
American International Group
New York
$224 – – –
VAM
42
Visium Asset Management
New York
– -$1.48M -54,545 Closed
PA
43
Perceptive Advisors
New York
– -$626K -23,036 Closed
BG
44
BlackRock Group
United Kingdom
– -$391K -14,400 Closed
BlackRock
45
BlackRock
New York
– -$304K -11,173 Closed
B
46
Bailard
California
– -$284K -10,455 Closed
TC
47
TFS Capital
Pennsylvania
– -$40K -1,459 Closed
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$5.41K -211 -99%
Group One Trading
49
Group One Trading
Illinois
– -$4K -145 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$2K -63 Closed
1
2
3

VXRT Hedge Fund Activity: Q4 2014 in Review

46 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2014, worth a combined $29.8M — up 0.85% from $29.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of VXRT and 7 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $3.21M. The largest seller was JP Morgan Chase, cutting an estimated $2.78M.

  • 46 institutional investors held Vaxart (VXRT) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $29.8M of Vaxart stock for Q4 2014, up 0.85% quarter-over-quarter.
  • 7 funds opened new Vaxart positions in Q4 2014 and 9 closed out, a net change of -2 holders.
  • The largest Vaxart buyer in Q4 2014 was RA Capital Management, an estimated $3.21M added.
  • The largest Vaxart seller in Q4 2014 was JP Morgan Chase, an estimated $2.78M sold.

Based on aggregated 13F filings for Q4 2014.